Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case–control study
Keywords: MetS, Metabolic syndrome; CVD, Cardiovascular disease; NF-κB, Nuclear factor-kB; IR, Insulin resistance; MMP, Matrix metalloproteinases; TNF-α, Tumor necrosis factor-alpha; ECM, Extracellular matrix; TIMP, Tissue inhibitor of matrix metalloproteinases; IR